World’s biggest multibillionaire investor is buying THIS by the ton [picture]

Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.

IMNM Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 20.00%

Insider Buying (Last 12 Months): $1,249,988.64

Insider Selling (Last 12 Months): $0.00

Immunome Insider Trading History Chart

Immunome Share Price & Price History

^$14.26

▼ -0.01 (-0.07%)

As of 04/25/2024 01:00 AM ET

Days: 30 | 90 | 365

These AI trades triggered this morning (545% return)

From Prosper Trading Academy | Ad

If you think a market crash is possible in 2024, I don't know why you're not using this yet.

Click Here To Get Your Free Copy

Immunome Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/2/2023	Bruce Turner	Insider	Buy	42,300	$5.91	$249,993.00	42,300
10/2/2023	Clay B Siegall	CEO	Buy	169,204	$5.91	$999,995.64	319,636
9/13/2021	Michael Rapp	Director	Buy	25,962	$19.96	$518,201.52	799,866
9/9/2021	Michael Rapp	Director	Buy	30,450	$18.19	$553,885.50	799,866
5/26/2021	Michael Lefenfeld	Director	Buy	1,335	$19.03	$25,405.05	22,822
5/25/2021	Purnanand D. Sarma	CEO	Buy	10,500	$18.41	$193,305.00	10,500
5/24/2021	Michael Lefenfeld	Director	Buy	600	$17.80	$10,680.00	46,726

These AI trades triggered this morning (545% return)

From Prosper Trading Academy | Ad

If you think a market crash is possible in 2024, I don't know why you're not using this yet.

Click Here To Get Your Free Copy

SEC Filings (Institutional Ownership Changes) for Immunome (NASDAQ:IMNM)

44.58% of Immunome stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Immunome Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/14/2024	Avidity Partners Management LP	1,333,479	$14.27M	0.5%	N/A	3.121%
2/13/2024	Mayo Clinic	108,480	$1.16M	7.2%	N/A	0.254%
2/7/2024	Jump Financial LLC	16,100	$0.17M	0.0%	N/A	0.038%
1/30/2024	Emfo LLC	59,165	$0.63M	0.6%	N/A	0.138%
1/26/2024	Cerity Partners LLC	61,346	$0.66M	0.0%	N/A	0.144%
11/13/2023	Acadian Asset Management LLC	49,712	$0.41M	0.0%	N/A	0.407%
11/7/2023	Dorsey Wright & Associates	3,100	$26K	0.0%	N/A	0.025%
10/27/2023	TD Asset Management Inc	127,280	$1.06M	0.0%	N/A	1.043%
8/15/2023	Prentice Capital Management LP	112,131	$0.89M	2.8%	-74.0%	0.919%
8/2/2023	Bank of Montreal Can	100,334	$0.80M	0.0%	N/A	0.822%
7/12/2023	Heron Bay Capital Management	13,139	$0.10M	0.0%	N/A	0.108%
2/14/2023	Susquehanna International Group LLP	22,064	$49K	0.0%	-9.2%	0.182%
8/10/2022	Cerity Partners LLC	56,962	$0.18M	0.0%	-39.1%	0.470%
5/17/2022	Prentice Capital Management LP	792,321	$4.50M	1.1%	-1.8%	6.532%
11/16/2021	Baldwin Investment Management LLC	9,196	$0.22M	0.0%	N/A	0.076%
11/15/2021	Marshall Wace LLP	8,348	$0.20M	0.0%	N/A	0.069%
11/12/2021	Geode Capital Management LLC	54,669	$1.33M	0.0%	+38.3%	0.452%
11/10/2021	HAP Trading LLC	17,922	$0.44M	0.0%	N/A	0.148%
11/9/2021	BlackRock Inc.	40,508	$0.99M	0.0%	+77.0%	0.335%
10/25/2021	Cerity Partners LLC	102,004	$2.48M	0.1%	-2.4%	0.843%
10/20/2021	Ridgewood Investments LLC	28,013	$0.68M	0.5%	-51.7%	0.232%
8/16/2021	Royal Bank of Canada	28,127	$0.49M	0.0%	+8,271.1%	0.239%
8/16/2021	Morgan Stanley	11,371	$0.20M	0.0%	+9,375.8%	0.097%
8/13/2021	Renaissance Technologies LLC	20,400	$0.35M	0.0%	N/A	0.174%
8/13/2021	Alpine Global Management LLC	854,671	$14.79M	2.0%	+7.4%	7.269%
8/13/2021	Neuberger Berman Group LLC	19,444	$0.34M	0.0%	N/A	0.165%
8/13/2021	Geode Capital Management LLC	39,529	$0.68M	0.0%	-19.9%	0.336%
8/13/2021	Vanguard Group Inc.	302,092	$5.23M	0.0%	+95.9%	2.569%
8/12/2021	Ergoteles LLC	10,006	$0.17M	0.0%	N/A	0.085%
8/9/2021	Wealth Architects LLC	11,201	$0.19M	0.0%	N/A	0.095%
8/6/2021	Magnus Financial Group LLC	25,759	$0.45M	0.1%	+75.9%	0.219%
7/31/2021	Sterling Investment Advisors Ltd.	21,627	$0.37M	0.1%	N/A	0.184%
7/31/2021	Ridgewood Investments LLC	58,013	$1M	0.6%	N/A	0.493%
5/18/2021	Prentice Capital Management LP	331,995	$11.25M	3.5%	-20.3%	2.824%
5/14/2021	O Shaughnessy Asset Management LLC	1,599	$54K	0.0%	N/A	0.015%
5/13/2021	Alpine Global Management LLC	795,709	$26.96M	2.6%	+0.7%	7.464%
5/12/2021	Northern Trust Corp	27,114	$0.92M	0.0%	+7.2%	0.254%
5/12/2021	Cerity Partners LLC	110,327	$3.74M	0.1%	-10.0%	1.035%
5/12/2021	Geode Capital Management LLC	49,331	$1.67M	0.0%	+225.0%	0.463%
5/11/2021	New York State Common Retirement Fund	3,650	$0.12M	0.0%	-33.0%	0.034%
5/7/2021	BlackRock Inc.	112,851	$3.82M	0.0%	+57.3%	1.059%
5/5/2021	Magnus Financial Group LLC	14,648	$0.50M	0.1%	N/A	0.137%
4/23/2021	Strs Ohio	1,400	$47K	0.0%	N/A	0.013%
2/19/2021	JPMorgan Chase & Co.	5,731	$55K	0.0%	N/A	0.054%
2/12/2021	Prentice Capital Management LP	416,667	$4.03M	1.1%	N/A	3.952%
2/12/2021	Kepos Capital LP	66,666	$0.65M	0.1%	N/A	0.632%
2/11/2021	Northern Trust Corp	25,287	$0.25M	0.0%	N/A	0.240%
2/11/2021	Cerity Partners LLC	122,546	$1.19M	0.0%	N/A	1.162%
2/8/2021	New York State Common Retirement Fund	5,450	$53K	0.0%	N/A	0.052%
2/6/2021	Granite Point Capital Management L.P.	66,666	$0.65M	0.0%	N/A	0.632%
2/5/2021	BlackRock Inc.	71,752	$0.70M	0.0%	N/A	0.681%

Data available starting January 2016

Immunome, Inc., a biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises AL102, an investigational gamma secretase inhibitor currently in evaluation in a Phase 3 trial for the treatment of desmoid tumors; and preclinical assets consist of IM-1021, a receptor tyrosine kinase-like orphan receptor 1 and antibody-drug conjugates, as well as IM-3050, a fibroblast activation protein targeted radioligand therapy; and IM-4320, an anti-IL-38 immunotherapy candidate. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.

Today's Range

Now: $14.26

$13.82

$14.58

50 Day Range

MA: $22.25

$14.26

$27.34

52 Week Range

Now: $14.26

$4.44

$30.96

Volume

736,699 shs

Average Volume

725,369 shs

Market Capitalization

$851.18 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.66

Who are the company insiders with the largest holdings of Immunome?: Immunome's top insider shareholders include:
Clay B Siegall (CEO)
Bruce Turner (Insider)
Learn More about top insider investors at Immunome.